IL6 and heart failure: Cainzos-Achirica et al evaluated the prognostic implications of IL-6 levels on hard coronary heart disease (CHD) events, stroke, hard atherosclerotic CVD, and incident heart failure (HF) in patients without clinical CVD using the MESA (Multi-Ethnic Study of Atherosclerosis); however, the analysis was focused on assessing differences between users and nonusers of statins and did not assess the impact of race and ethnicity on clinical outcomes.11